AUG 22, 2013 05:00 PM PDT

Clinical Utility Potential of Epigenetic Aberrations in Human Solid Tumors

Speakers
  • Chief of Scientific Intelligence, Director of Molecular Oncology, John Wayne Cancer Institute

Abstract:
As Chief of Scientific Intelligence at the John Wayne Cancer Institute, Dr. Hoon interacts with external academic, industry, and government agencies to develop innovative translational research opportunities. He has coauthored more than 250 peer-reviewed articles and reviews, primarily related to translational molecular oncology of human solid tumors. He has over 25 patents on his studies. As founding Director of the Department of Molecular Oncology, Dr. Hoon continues to pioneer investigations of RNA/genomic/epigenomic biomarkers for diagnostic, prognostic and predictive assessment of residual tumor cells. He also spearheads investigations of circulating DNA/miRNA biomarkers for staging cancer in patients enrolled in phase II/III clinical trials. The Department's focus on biomarker expression in both tissue and body-fluid specimens gives it a uniquely broad scope. Dr. Hoon's team has developed diagnostic tissue biomarkers for molecular staging of sentinel lymph nodes and classification of human solid tumors such as melanoma, breast cancer and gastrointestinal cancer. Dr. Hoon also has pioneered development of blood-based nucleic-acid and tumor-cell biomarkers as prognostic tools. In the last decade he and his team have designed and conducted biomarker companion studies as part of multicenter international clinical trials. On the therapeutic front, Dr. Hoon is examining functional genomic and epigenomic changes as potential targets for development of novel approaches to treat or prevent malignancy. Dr. Hoon and the Department are funded by the National Institutes of Health/National Cancer Institute, the California Breast Cancer Research Program, Susan G. Komen for the Cure, Adelson Melanoma Research Foundation, the United States Department of Defense, and the pharma-biotech industry. Dr. Hoon has served on several review study sections as a permanent member for the National Cancer Institute, and was a founding member of NCI's Cancer Biomarker Study Section. The Department of Molecular Oncology consists of over 20 MD/PhD scientists and research technicians focused on translation molecular oncology. Some of the major ongoing collaborations include: Leiden University Medical Center, Netherlands; Genome Institute Singapore, Biopolis; Broad Institute of MIT and Harvard; Keio University; MD Anderson, and Melanoma Institute Australia. Dr. Hoon has trained more than 60 postdoctoral oncology fellows, who now hold faculty appointments in numerous academic institutions.    

Show Resources
You May Also Like
SEP 05, 2019 04:00 PM CEST
C.E. CREDITS
SEP 05, 2019 04:00 PM CEST
DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
AUG 27, 2019 09:00 AM PDT
C.E. CREDITS
AUG 27, 2019 09:00 AM PDT
DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
JUN 05, 2019 05:00 PM CEST
C.E. CREDITS
JUN 05, 2019 05:00 PM CEST
DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
OCT 02, 2019 11:00 AM PDT
OCT 02, 2019 11:00 AM PDT
DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
NOV 18, 2019 07:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 18, 2019 07:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
JUN 26, 2019 09:00 AM PDT
C.E. CREDITS
JUN 26, 2019 09:00 AM PDT
DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
Loading Comments...
Show Resources